Publications by authors named "Meg Finch-Jones"

Claim this Profile
L
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.
John Bridgewater, Peter Fletcher, Daniel H Palmer, Hassan Z Malik, Raj Prasad, Meg Finch-Jones

J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microscopic resection margins adversely influence survival rates after surgery for colorectal liver metastases: An open ambidirectional Cohort Study.
Keng Siang Lee, Ivo Suchett-Kaye, Reyad Abbadi, Meg Finch-Jones, Ian Pope

Int J Surg· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
John N Primrose, Richard P Fox, Daniel H Palmer, Hassan Z Malik, Raj Prasad, Meg Finch-Jones

Lancet Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
Siân A Pugh, Megan Bowers, Alexandre Ball, Stephen Falk, Meg Finch-Jones

Br J Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab Is Contraindicated in the Perioperative Treatment of Colorectal Liver Metastases.
John N Primrose, David Cunningham, O James Garden, Tim S Maughan, Siân A Pugh, Meg Finch-Jones

J Clin Oncol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.
John Primrose, Stephen Falk, Meg Finch-Jones, Juan Valle, Derek O'Reilly

Lancet Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, Graeme J Poston, Peter M Schlag, Meg Finch-Jones

Lancet Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983).
Halfdan Sorbye, Murielle Mauer, Thomas Gruenberger, Bengt Glimelius, Graeme J Poston, Meg Finch-Jones

Ann Surg· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast-enhanced intraoperative ultrasound improves detection of liver metastases during surgery for primary colorectal cancer.
Ankur J Shah, Mark Callaway, Michael G Thomas, Meg D Finch-Jones

HPB (Oxford)· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, Graeme J Poston, Peter M Schlag, Meg Finch-Jones

Lancet· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis